Press Release: Monitor China NMPA Inspections & Recalls

Global Key Solutions is excited to announce the launch of our China NMPA Inspection & Recall Monitoring feature, providing teams with up-to-date insights into Chinese drug inspection and enforcement activity.

Quality and regulatory teams can now track China's National Medical Products Administration (NMPA) unannounced inspections, routine drug inspections, and product recalls, delivering visibility into one of the world's largest and most consequential regulatory markets.

This enhancement reinforces GKS's ongoing mission to support transparent, data-driven compliance for life science organizations worldwide.

Want to experience the new addition? Book a meeting here.